References
- AkinbamiLJMoormanJEBaileyCTrends in asthma prevalence, health care use, and mortality in the United States, 2001–2010NCHS Data Brief2012941822617340
- AkinbamiLJSullivanSDCampbellJDAsthma outcomes: healthcare utilization and costsJ Allergy Clin Immunol20121293 SupplS49S6422386509
- BlackwellDLLJClarkeTCSummary health statistics for US adults: National Health Interview Survey, 2012. National Center for Health StatisticsVital Health Stat20142601161
- MooreWCMeyersDAWenzelSEIdentification of asthma phenotypes using cluster analysis in the Severe Asthma Research ProgramAm J Respir Crit Care Med2010181431532319892860
- National Asthma Education and Prevention ProgramExpert panel report 3 (EPR-3): guidelines for the diagnosis and management of asthma-summary report 2007J Allergy Clin Immunol20071205 SupplS94S13817983880
- NairPWhat is an “eosinophilic phenotype” of asthma?J Allergy Clin Immunol20131321818323727039
- StoneKDPrussinCMetcalfeDDIgE, mast cells, basophils, and eosinophilsJ Allergy Clin Immunol20101252 Suppl 2S73S8020176269
- RothenbergMEHoganSPThe eosinophilAnnu Rev Immunol20062414717416551246
- ZhangJYWenzelSETissue and BAL based biomarkers in asthmaImmunol Allergy Clin North Am2007274623632vi17996580
- BousquetJChanezPLacosteJYEosinophilic inflammation in asthmaN Engl J Med199032315103310392215562
- WardlawAJBrightlingCEGreenRWoltmannGBraddingPPavordIDNew insights into the relationship between airway inflammation and asthmaClin Sci (Lond)2002103220121112149112
- LeeJJJacobsenEAMcGarryMPSchleimerRPLeeNAEosinophils in health and disease: the LIAR hypothesisClin Exp Allergy201040456357520447076
- Nissim Ben EfraimAHLevi-SchafferFTissue remodeling and angiogenesis in asthma: the role of the eosinophilTher Adv Respir Dis20082316317119124368
- WenzelSESchwartzLBLangmackELEvidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristicsAm J Respir Crit Care Med199916031001100810471631
- WoodruffPGModrekBChoyDFT-helper type 2-driven inflammation defines major subphenotypes of asthmaAm J Respir Crit Care Med2009180538839519483109
- ChungKFWenzelSEBrozekJLInternational ERS/ATS guidelines on definition, evaluation and treatment of severe asthmaEur Respir J201443234337324337046
- WenzelSSevere asthma in adultsAm J Respir Crit Care Med2005172214916015849323
- SehmiRWardlawAJCromwellOKuriharaKWaltmannPKayABInterleukin-5 selectively enhances the chemotactic response of eosinophils obtained from normal but not eosinophilic subjectsBlood19927911295229591316789
- GarciaGTailleCLavenezianaPBourdinAChanezPHumbertMAnti-interleukin-5 therapy in severe asthmaEur Respir Rev20132212925125723997052
- GleichGJMechanisms of eosinophil-associated inflammationJ Allergy Clin Immunol2000105465166310756213
- YamaguchiYSudaTSudaJPurified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursorsJ Exp Med1988167143563257253
- FosterPSHoganSPRamsayAJMatthaeiKIYoungIGInterleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma modelJ Exp Med199618311952018551223
- LeeJJMcGarryMPFarmerSCInterleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthmaJ Exp Med199718512214321569182686
- HamidQAzzawiMYingSExpression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthmaJ Clin Invest1991875154115462022726
- HumbertMCorriganCJKimmittPTillSJKayABDurhamSRRelationship between IL-4 and IL-5 mRNA expression and disease severity in atopic asthmaAm J Respir Crit Care Med19971563 Pt 17047089309982
- LamblinCGossetPSalezFEosinophilic airway inflammation in nasal polyposisJ Allergy Clin Immunol19991041859210400844
- RobinsonDHamidQBentleyAYingSKayABDurhamSRActivation of CD4+ T cells, increased TH2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthmaJ Allergy Clin Immunol19939223133248349942
- RobinsonDSYingSBentleyAMRelationships among numbers of bronchoalveolar lavage cells expressing messenger ribonucleic acid for cytokines, asthma symptoms, and airway methacholine responsiveness in atopic asthmaJ Allergy Clin Immunol19939233974038360390
- ShiHZXiaoCQZhongDEffect of inhaled interleukin-5 on airway hyperreactivity and eosinophilia in asthmaticsAm J Respir Crit Care Med199815712042099445301
- LeckieMJten BrinkeAKhanJEffects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic responseLancet200035692482144214811191542
- Flood-PagePSwensonCFaifermanIA study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthmaAm J Respir Crit Care Med2007176111062107117872493
- NairPPizzichiniMMKjarsgaardMMepolizumab for prednisone-dependent asthma with sputum eosinophiliaN Engl J Med20093601098599319264687
- Flood-PagePMenzies-GowAPhippsSAnti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmaticsJ Clin Invest200311271029103614523040
- HaldarPBrightlingCEHargadonBMepolizumab and exacerbations of refractory eosinophilic asthmaN Engl J Med20093601097398419264686
- EsnaultSKellyEAShenZJJohanssonMWMalterJSJarjourNNIL-3 maintains activation of the p90S6K/RPS6 pathway and increases translation in human eosinophilsJ Immunol201519562529253926276876
- EsnaultSMalterJSGranulocyte macrophage-colony-stimulating factor mRNA is stabilized in airway eosinophils and peripheral blood eosinophils activated by TNF-alpha plus fibronectinJ Immunol200116674658466311254725
- PavordIDKornSHowarthPMepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trialLancet2012380984265165922901886
- OrtegaHGLiuMCPavordIDMepolizumab treatment in patients with severe eosinophilic asthmaN Engl J Med2014371131198120725199059
- BelEHWenzelSEThompsonPJOral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthmaN Engl J Med2014371131189119725199060
- CastroMMathurSHargreaveFReslizumab for poorly controlled, eosinophilic asthma: a randomized, placebo-controlled studyAm J Respir Crit Care Med2011184101125113221852542
- KipsJCO’ConnorBJLangleySJEffect of SCH55700, a humanized anti-human interleukin-5 antibody, in severe persistent asthma: a pilot studyAm J Respir Crit Care Med2003167121655165912649124
- BatemanNDShahiAFeeleyKMWoolfordTJActivated eosinophils in nasal polyps: a comparison of asthmatic and non-asthmatic patientsClin Otolaryngol200530322122516111416
- GevaertPLang-LoidoltDLacknerANasal IL-5 levels determine the response to anti-IL-5 treatment in patients with nasal polypsJ Allergy Clin Immunol200611851133114117088140
- BjermerCLMasperoJorgeCiesielskaMonikaO’BrienChristopherZangrilliJamesA randomized phase 3 study of the efficacy and safety of reslizumab in subjects with asthma with elevated eosinophilsEuropean Respiratory Journal2014445829925082909
- GhaziATrikhaACalhounWJBenralizumab – a humanized mAb to IL-5Ralpha with enhanced antibody-dependent cell-mediated cytotoxicity – a novel approach for the treatment of asthmaExpert Opin Biol Ther201212111311822136436
- CastroMWenzelSEBleeckerERBenralizumab, an anti-interleukin 5 receptor alpha monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging studyLancet Respir Med201421187989025306557
- JatakanonALimSKharitonovSAChungKFBarnesPJCorrelation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthmaThorax199853291959624291
- SchleichFNSeidelLSeleJExhaled nitric oxide thresholds associated with a sputum eosinophil count >/=3% in a cohort of unselected patients with asthmaThorax201065121039104420671307
- WesterhofGAKorevaarDAAmelinkMBiomarkers to identify sputum eosinophilia in different adult asthma phenotypesEur Respir J201546368869626113672
- WagenerAHde NijsSBLutterRExternal validation of blood eosinophils, FE(NO) and serum periostin as surrogates for sputum eosinophils in asthmaThorax201570211512025422384
- JiaGEricksonRWChoyDFPeriostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patientsJ Allergy Clin Immunol20121303647654.e1022857879